When was HiRO founded?

HiRO was founded in 2020 and raised its 1st funding round 2 years after it was founded.

Where is HiRO located?

HiRO is headquartered in Shanghai, China.

How many employees does HiRO have?

As of Jul 01, 2024, the latest employee count at HiRO is 16.

Is HiRO a funded company?

HiRO is a funded company, having raised a total of $***** in its 1st and only funding round, a Series A round on Mar 18, 2022.

When was the latest funding round of HiRO?

HiRO's latest funding was a $***** Series A round on Mar 18, 2022, with participation from 2 investors.

Where does HiRO rank among its competitors?

HiRO ranks 73rd amongst 366 active competitors, of which 41 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Full-Life Technologies, which secured $50M in Sep, 2025.

Who are the top competitors of HiRO?

HiRO's top competitors include Novartis, Catalent and Surrozen. Among them, Full-Life Technologies secured the most recent funding round in September, 2025.

HiRO - 2026 Company Profile, Funding & Competitors

HiRO is a series A company based in Shanghai (China), founded in 2020. It operates as a Provider of clinical research & development, data operations, and regulatory affair services. HiRO has raised an undisclosed amount in funding from Orbimed. The company has 366 active competitors, including 41 funded and 51 that have exited. Its top competitors include companies like Novartis, Catalent and Surrozen.

Company Details

Website: harvestiro.com
Email ID: *****@harvestiro.com
Phone Number: +86 **********

Key Metrics

Founded Year

2020

Location

Shanghai, China

Stage

Series A

Latest Funding Round

Series A, Mar 18, 2022, $*****

Investors

Orbimed & 2 more

Ranked

73^rd among 366 active competitors

Employee Count

16 as on Jul 01, 2024

Investment & Acquisitions

DeltaMed Solutions & 1 more

Similar Companies

Novartis & 418 more

View HiRO's full profile

HiRO has raised funding over 1 round. Its latest funding round was a Series A round on Mar 18, 2022 for $*****. 2 investors participated in its latest round. HiRO has 3 institutional investors.

Here is the list of recent funding rounds of HiRO:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Mar 18, 2022	9367591	Series A	5995735	4249486	7904222	8378222

Access funding benchmarks and valuations. Sign up today!

View details of HiRO's funding rounds and investors

HiRO's employee count trend

HiRO has 16 employees as of Jul 24. Here is HiRO's employee count trend over the years:

Uncover HiRO's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of HiRO include Novartis, Catalent and Surrozen. Here is the list of Top 10 competitors of HiRO, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Novartis 1996, Basel (Switzerland), Public	R&D focused on manufacturing of drugs for multiple therapeutic areas	-	Atlas Venture, Digital Pharma Lab & 9 others	70/100
2nd	Catalent 2007, Somerset (United States), Acquired	Provider of development, manufacturing, and packaging solutions for medicines and supplements	-	Aisling Capital, Genstar Capital & 3 others	68/100
3rd	Surrozen 2016, San Francisco (United States), Public	Pioneering targeted regenerative antibodies to repair tissue and restore organ function	$133M	The Column Group, Horizons Ventures & 13 others	66/100
4th	Biotage 1989, Uppsala (Sweden), Acquired	Organic synthesis, analytical, and peptide chemistry services for drug discovery and development	-	Taaleri, Investor Growth Capital & 4 others	60/100
5th	BioFactura 2004, Frederick (United States), Series B	Biosimilars, biodefense, and biomanufacturing company dedicated to innovation and global biomedical needs	$7.8M	Wilson Sonsini Goodrich & Rosati, UVM Health ... & 2 others	56/100
6th	Full-Life Technologies 2021, Shanghai (China), Series C	Provider of discovery, development, production, and logistics services for of nuclear medicines	$200M	Chengwei Capital, Junson Capital & 15 others	55/100
7th	Tirupati Medicare 1980, Paonta Sahib (India), Series B	Contract manufacturer of pharmaceutical products	$51.5M	internationalcylinders.com, TBO & 26 others	55/100
8th	Acclinate 2020, Birmingham (United States), Series A	Provider of clinical trial services to biopharma sector	$12M	Cencora, Alabama Launchpad & 7 others	54/100
9th	AmplifyBio 2021, Hilliard (United States), Deadpooled	Provider of contract research, development, and manufacturing services for biologic drugs	$230M	Casdin Capital, Hercules Capital	53/100
10th	Curia 1991, Albany (United States), Acquired	Provider of drug research & development, testing, and consulting services	-	The Carlyle Group, HarbourVest Partners & 3 others	52/100
73rd	HiRO 2020, Shanghai (China), Series A	Provider of clinical research & development, data operations, and regulatory affair services	-	Orbimed, Panacea Venture & 1 others	29/100